TrustCore Financial Services’s Corcept Therapeutics CORT Stock Holding History

TrustCore Financial Services’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$4.24M	Hold	208,806	–	–	0.37%	35
2022 Q3	$5.35M	Hold	208,806	–	–	0.51%	28
2022 Q2	$4.96M	Hold	208,806	–	–	0.46%	29
2022 Q1	$4.7M	Buy	208,806 +570	+0.3%	+$12.1K	0.41%	33
2021 Q4	$4.12M	Sell	208,236 -8,459	-4%	-$172K	0.47%	30
2021 Q3	$4.26M	Buy	216,695 +130,000	+150%	+$2.72M	0.42%	32
2021 Q2	$1.91M	Hold	86,695	–	–	0.2%	58
2021 Q1	$2.06M	Sell	86,695 -20,000	-19%	-$534K	0.24%	52
2020 Q4	$2.79M	Buy	106,695 +45,765	+75%	+$964K	0.36%	36
2020 Q3	$1.06M	Buy	60,930 +40,160	+193%	+$640K	0.16%	76
2020 Q2	$349K	Sell	20,770 -63,198	-75%	-$888K	0.06%	173
2020 Q1	$998K	Hold	83,968	–	–	0.22%	70
2019 Q4	$1.02M	Buy	83,968 +63,900	+318%	+$890K	0.19%	83
2019 Q3	$284K	Sell	20,068 -29,500	-60%	-$362K	0.06%	176
2019 Q2	$553K	Hold	49,568	–	–	0.12%	116
2019 Q1	$582K	Buy	+49,568	New	+$616K	0.16%	83
2018 Q4	–	Sell	-49,568	Closed	-$695K	–	480
2018 Q3	$695K	Buy	49,568 +49,085	+10,163%	+$686K	0.22%	66
2018 Q2	$8K	Hold	483	–	–	﹤0.01%	595
2018 Q1	$8K	Buy	+483	New	+$8.95K	﹤0.01%	530

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TrustCore Financial Services's CORT Position: Q4 2022 in Review

TrustCore Financial Services held its Corcept Therapeutics (CORT) position steady in Q4 2022 at 208,806 shares worth $4.24M. The position accounts for 0.37% of the portfolio, ranked #35.

TrustCore Financial Services first reported a position in CORT in Q1 2018 and has held it in 19 quarters since. The position peaked at $5.35M in Q3 2022. 241 funds tracked by Wall St. Rank hold CORT as of Q4 2022.

TrustCore Financial Services held 208,806 shares of Corcept Therapeutics worth $4.24M as of Q4 2022.
TrustCore Financial Services left its Corcept Therapeutics share count unchanged in Q4 2022.
Corcept Therapeutics made up 0.37% of TrustCore Financial Services's portfolio in Q4 2022, its #35 holding.
TrustCore Financial Services first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 19 quarters since.
TrustCore Financial Services's Corcept Therapeutics position peaked at $5.35M in Q3 2022.
241 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.